These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diagnosis of adrenal medullary diseases in patients with sporadic or hereditary medullary thyroid carcinoma. A report of 37 cases with 8-year follow-up study]. Miyauchi A; Matsuzaka F; Kuma K; Endo K; Ogihara T; Maeda M Nihon Geka Gakkai Zasshi; 1987 Oct; 88(10):1423-9. PubMed ID: 2892121 [TBL] [Abstract][Full Text] [Related]
3. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Brown MJ; Allison DJ; Jenner DA; Lewis PJ; Dollery CT Lancet; 1981 Jan; 1(8213):174-7. PubMed ID: 6109856 [TBL] [Abstract][Full Text] [Related]
4. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers. Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276 [TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma. Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma. McHenry CM; Hunter SJ; McCormick MT; Russell CF; Smye MG; Atkinson AB J Hum Hypertens; 2011 Jul; 25(7):451-6. PubMed ID: 20811397 [TBL] [Abstract][Full Text] [Related]
7. Serotonin (5-hydroxytryptamine) in medullary thyroid carcinoma with or without pheochromocytoma. Engbaek F Eur J Cancer Clin Oncol; 1985 Apr; 21(4):469-73. PubMed ID: 2861094 [TBL] [Abstract][Full Text] [Related]
8. Catecholamine release after physical exercise. A new provocative test for early diagnosis of pheochromocytoma in multiple endocrine neoplasia type 2. Telenius-Berg M; Adolfsson L; Berg B; Hamberger B; Nordenfelt I; Tibblin S; Welander G Acta Med Scand; 1987; 222(4):351-9. PubMed ID: 2892350 [TBL] [Abstract][Full Text] [Related]
9. Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma. Mannelli M; De Feo ML; Maggi M; Pupilli C; Opocher G; Valenza T; Baldi E; Serio M J Endocrinol Invest; 1987 Aug; 10(4):377-82. PubMed ID: 2890684 [TBL] [Abstract][Full Text] [Related]
10. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases. Gerlo EA; Sevens C Clin Chem; 1994 Feb; 40(2):250-6. PubMed ID: 7906208 [TBL] [Abstract][Full Text] [Related]
11. Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction. Gross MD; Shapiro B; Sisson JC; Zweifler A J Endocrinol Invest; 1987 Aug; 10(4):359-64. PubMed ID: 2890683 [TBL] [Abstract][Full Text] [Related]
12. A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma. Lee GR; Johnston PC; Atkinson AB; McKillop D; Auld P; Hunter SJ J Hypertens; 2011 Dec; 29(12):2422-8. PubMed ID: 22002333 [TBL] [Abstract][Full Text] [Related]
13. Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Plouin PF; Duclos JM; Menard J; Comoy E; Bohuon C; Alexandre JM Br Med J (Clin Res Ed); 1981 Mar; 282(6267):853-4. PubMed ID: 6783201 [TBL] [Abstract][Full Text] [Related]
14. Phaeochromocytomas secreting adrenaline but not noradrenaline do not cause hypertension and require precise adrenaline measurement for diagnosis. Bachmann AW; Hawkins PG; Gordon RD Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):275-9. PubMed ID: 2743619 [TBL] [Abstract][Full Text] [Related]
15. [Measurement of platelet catecholamine content for the diagnosis of pheochromocytoma with intermittent hypertension]. Plouin PF; Chatellier G; Billaud-Mesguich E; Comoy E; Duclos JM; Ménard J Arch Mal Coeur Vaiss; 1987 Jun; 80(6):812-5. PubMed ID: 3116976 [TBL] [Abstract][Full Text] [Related]
16. Plasma atrial natriuretic factor and catecholamines before and during excision of pheochromocytoma. Donckier JE; Michel LA; Collard E; Galanti L; Harvengt C; Berbinschi A; Ketelslegers JM; Buysschaert M Acta Chir Belg; 1991; 91(2):112-6. PubMed ID: 1676862 [TBL] [Abstract][Full Text] [Related]
17. Chromogranin A, a member of neuroendocrine secretory proteins as a selective marker for laboratory diagnosis of pheochromocytoma. Bílek R; Šafařík L; Ciprová V; Vlcek P; Lisá L Physiol Res; 2008; 57 Suppl 1():S171-S179. PubMed ID: 18271679 [TBL] [Abstract][Full Text] [Related]
18. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. Gagel RF; Tashjian AH; Cummings T; Papathanasopoulos N; Kaplan MM; DeLellis RA; Wolfe HJ; Reichlin S N Engl J Med; 1988 Feb; 318(8):478-84. PubMed ID: 2893259 [TBL] [Abstract][Full Text] [Related]
19. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma. Peaston RT; Lennard TW; Lai LC J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337 [TBL] [Abstract][Full Text] [Related]
20. The catecholamine concentration in central veins of hypertensive patients--an aid not without problems in locating phaeochromocytoma. Collste P; Brismar B; Alveryd A; Björkhem I; Hårdstedt C; Svensson L; Ostman J Acta Chir Scand Suppl; 1986; 530():67-71. PubMed ID: 3460293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]